Dr. Binita Shah was awarded her MD and a Master of Science in clinical investigation from NYU School of Medicine and completed her Interventional Cardiology fellowship at NYU.

Dr. Shah is an associate professor of medicine at NYU School of Medicine, director of research for interventional Cardiology at NYU Langone Health, and co-director of research for NYU Langone Heart. She is also an associate director of interventional cardiology and director of the transcatheter valve program at the VA New York Harbor Healthcare System. Dr. Shah conducts clinical translational research and utilizes a multi-disciplinary approach to the treatment of coronary artery disease and acute coronary syndrome with a focus on optimization of the underlying inflammatory and glucometabolic milieu. She was a KL2 scholar, recipient of grants from the American College of Cardiology Foundation and the American Heart Association clinical research program, and principal investigator of the randomized VA-funded Colchicine-PCI trial and NIH-funded ColCorona-US study. Dr. Shah is currently the principal investigator of the ongoing NIH-funded CLEAR SYNERGY Biospecimen substudy and the VA-funded multicenter randomized POPCORN trial.

Dr. Shah serves on multiple national committees through the Society of Cardiovascular Angiography and Interventions, the American College of Cardiology, and the American Heart Association, including its Leadership Committee of the Council on Clinical Cardiology. She is also Associate Editor for Circulation Cardiovascular Intervention and serves on the Society of Cardiovascular Angiography and Interventions Board of Trustees.